(Q43811406)

English

Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography

scientific article published on 11 November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Alzheimer's disease

0 references

mild cognitive impairment

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

based on heuristic

inferred from title

author name string

Kai Kendziorra

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Henrike Wolf

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Philipp Mael Meyer

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Henryk Barthel

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Swen Hesse

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Georg Alexander Becker

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Julia Luthardt

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Andreas Schildan

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Marianne Patt

9

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dietlind Sorger

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Anita Seese

11

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Herman-Josef Gertz

12

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Osama Sabri

13

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

11 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

515-525

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Cholinergic markers in elderly patients with early signs of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Nicotinic acetylcholine binding sites in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Impaired axonal transport of cortical neurons in Alzheimer's disease is associated with neuropathological changes

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Neuronal Nicotinic Receptor Subtypes

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

2-[18F]Fluoro-A-85380, an in vivo tracer for the nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Synthesis procedure for routine production of 2-[18F]fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-[18F]F-A-85380).

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Binding properties of the cerebral alpha4beta2 nicotinic acetylcholine receptor ligand 2-[18F]fluoro-A-85380 to plasma proteins

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Measurement of the alpha4beta2* nicotinic acetylcholine receptor ligand 2-[(18)F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Graphical analysis of 2-[18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Quantification of cerebral nicotinic acetylcholine receptors by PET using 2-[18F]fluoro-A-85380 and the multiinjection approach

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

alpha4beta2-nicotinic receptor binding with 5-IA in Alzheimer's disease: methods of scan analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Alzheimer's disease as a presumptive threshold phenomenon

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Decreased uptake and binding of 11C-nicotine in brain of Alzheimer patients as visualized by positron emission tomography

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Relationship between nicotinic receptors and cognitive function in early Alzheimer's disease: a 2-[18F]fluoro-A-85380 PET study.

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

123I-5-IA-85380 SPECT imaging of nicotinic receptors in Alzheimer disease and mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Using cerebral white matter for estimation of nondisplaceable binding of 5-HT1A receptors in temporal lobe epilepsy

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

5-(123)I-A-85380 binding to the α4β2-nicotinic receptor in mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1644-5

21 January 2018

A truly simultaneous combination of functional transcranial Doppler sonography and H(2)(15)O PET adds fundamental new information on differences in cognitive activation between schizophrenics and healthy control subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21069319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

123I-5-IA-85380 SPECT measurement of nicotinic acetylcholine receptors in human brain by the constant infusion paradigm: feasibility and reproducibility

1 reference

https://pubmed.ncbi.nlm.nih.gov/21069319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains--in vivo assessment using positron emission tomography.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21069319

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-010-1644-5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43811406&oldid=2206273073"